Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the USA / NCT06741514
Enrolling by invitation Observational

A Study of Precice Intramedullary Limb Lengthening System (IMLL) Limb Lengthening Procedures

NCT06741514 · tracked via the Priya Life Science USA tracker
Sponsor
NuVasive
Phase
Observational
Started
2024-03-25
Last updated
2025-12-18

Condition(s) studied

Limb Length Discrepancy

Investigational drug(s) / intervention(s)

Precice IMLL

Precice IMLL: Parents or legal guardians of children that previously received the Precice IMLL will complete a survey. No additional or new interventions will be administered.

Study summary

The Sponsor is conducting a survey to understand how parents or legal guardians feel about the benefits of using the Precice IMLL System to lengthen limbs in children who are 12 years old or younger.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * To be eligible for inclusion in this perceived clinical benefit survey study, the following inclusion criteria must be met: 1. Participants must be a parent or legal guardian of a subject already enrolled in the Precice IMLL arm of the study, "A Retrospective Review of the Clinical and Radiographic Outcomes Following the Use of the Precice Intramedullary Limb Lengthening System (IMLL) in Pediatric Limb Lengthening Procedures" (NUVA.IMLL0723). 2. The parent or legal guardian must be familiar with the patient's preoperative and postoperative condition, surgical treatment, postoperative care, and clinical outcomes. 3. Informed consent from the parent or legal guardian of the patient is required for participation. Exclusion Criteria: * There are no exclusion criteria.

Primary outcome measure(s)

  • Perceived clinical benefits of the Precice Intramedullary Limb Lengthening (IMLL) Survey System — 1 year post-op
    Non-validated survey to assess the perceived clinical benefits of the Precice Intramedullary Limb Lengthening (IMLL) System in limb lengthening procedures in pediatric patients ages 12 years and younger as reported by parents or legal guardians.

Trial sites (2)

FacilityCityRegionStatus
Paley Orthopedic and Spine Institute West Palm Beach Florida
Nationwide Childrens Hospital Columbus Ohio

More NuVasive trials in the USA

Cervical Interbody Implant Study Enrolling by invitation
NuVasive® ACP System Study Enrolling by invitation
Lumbar Interbody Implant Study Enrolling by invitation
A Review of Precice Intramedullary Limb Lengthening (IMLL) System for Limb Lengthening Procedures in Children. Enrolling by invitation
Advanced Materials Science in XLIF Study Enrolling by invitation

Other trials for the same condition

A Review of Precice Intramedullary Limb Lengthening (IMLL) System for Limb Lengthening Procedures in Children. Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06741514 on ClinicalTrials.gov ↗ ← All trials in the USA